Tonmya Tablet, Orally Disintegrating
Product Images NDC 70792-102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tonmya (NDC 70792-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tonix Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 Trial 1 (Tonmya 02)
Figure 1 Trial 3 (Tonmya 03)
Figure 2 Trial 1 (Tonmya 04)
Figure 2 Trial 3 (Tonmya 05)
Principal Display Panel (2.8 mg Tablet Bottle Label)
This appears to be the label of a medication called TONMYya™ containing 28mg of Lobenzaprine HCI per sublingual tablet. The text provides information on proper storage conditions, including keeping the medication at a temperature between 20°C and 25°C and protecting it from moisture. It also advises keeping the medication out of reach of children and storing it in the original container with the desiccant canister. The label also includes the NDC (National Drug Code) number, quantity (90 tablets), and contact information for the manufacturer in Chatham, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.